COVID-19 vaccine clinical trials: 17 volunteers given doses of Russia's Sputnik V in Pune

Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.

PUNE: A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said on Sunday. Sputnik V vaccine has been developed by the Gamaleya National Research Center of Epidemiology and Microbiology and Russian Direct Investment Fund (RDIF). As per reports, India has purchased 100 million doses of the candidate from Russia.

"Seventeen healthy volunteers were administered Sputnik V vaccine in the last three days as part of human trials," Dr S K Raut, Head of Clinical Research Department of Noble Hospital here, said.

The inoculation process began on Thursday, he added.


"All the volunteers, who were administered the vaccine, will be under observation for the next few days," Dr Raut added.

The selection of the volunteers was done as per the laid-down norms as they need to be healthy, doctors said.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Industry › Healthcare/Biotech › Biotech › COVID-19 vaccine clinical trials: 17 volunteers given doses of Russia's Sputnik V in Pune
Text Size:AAA
Success
This article has been saved

*

+